GATA3 protein expression is a favourable prognostic indicator in ER-positive breast tumours, and numerous studies have reported that loss of GATA3 expression is associated with poor prognosis and propensity for tumour metastasis [18, 20, 23]. This evidence concerns the gene GATA3 and neoplasm.